Book a demo

Hybrid PET/MR & PET/CT Patents: Leader, Long Tail 2026

Hybrid PET/MR & PET/CT Patents: Leader, Long Tail 2026
Data to 2026-07-31

Hybrid PET/MR and PET/CT System Patents: Who Holds Attenuation-Map and Co-Registration Claims

One assignee dominates the ranked field: the leader holds 65 records against a fifth-place count of 4 and a tenth-place count of 2, across 33 ranked companies. Filing peaked so far in 2019 at 7 records and has not exceeded that level since. With fewer than four complete years remaining once the roughly 18-month publication lag is accounted for, a growth rate cannot be stated reliably from this trend alone — treat the most recent bars as a floor, not a ceiling.

Filing trend, 2017–2026
Complete Incomplete
Filing trend, 2017–2026024680201720187201920202021202220232024202502026Most recent year is partial — publication lag means later filings are not yet visible.
104
Published Records
US
Leading Jurisdiction
33
Active Filers Ranked
2019
Peak Filing Year
Top filers · published records
  1. 1KONINKLIJKE PHILIPS NV65
  2. 2SHANGHAI UNITED IMAGING HEALTHCARE15
  3. 3PHILIPS INTPROP & STANDARDS GMBH13
  4. 4SIEMENS MEDICAL SOLUTIONS USA INC6
  5. 5GE PRECISION HEALTHCARE LLC4
Published by Patsnap Research·

See the full hybrid pet/mr and pet/ct systems analysis in Eureka

  • The complete ranking, not just the top five
  • Every IPC branch with its share of the corpus
  • The most-cited records, and where claim space is still thin
Read more about this analysis in Eureka
FAQ

Common questions on hybrid PET/MR and PET/CT patents

Who holds the most patents on hybrid PET/MR and PET/CT systems?+

One assignee leads the ranked field with 65 records, far ahead of the fifth-ranked company’s 4 records and the tenth-ranked company’s 2. The ranking covers 33 companies total drawn from 104 records in scope, so the field has one dominant filer and a long tail of narrower, specific filers. Anyone assessing freedom-to-operate on core attenuation-correction or co-registration methods should check this leader’s portfolio first, since its filing volume covers most of the foundational correction techniques in this dataset.

What is an attenuation map and why does it matter for hybrid PET/MR patents?+

In PET imaging, photon attenuation as radiation passes through tissue must be corrected for accurate reconstruction, and that correction relies on an attenuation map normally derived from a CT or MR scan. In hybrid systems, the morphological scan is often truncated relative to the PET field of view, leaving gaps in the map — a problem that a large share of the filings in this dataset (grouped under image data processing and radiation measurement IPC classes) exist specifically to solve. It matters for patent strategy because it is the single busiest claim area in the field, meaning new filings here face the densest prior art.

Why has patent filing for hybrid PET/MR and PET/CT systems not grown recently?+

The filing trend in this dataset peaked at 7 records in 2019 and has not exceeded that level in any subsequent year through the 2026 data cut-off. That does not necessarily mean interest is declining — publication typically lags actual filing by roughly 18 months, so the most recent one to two years in any trend chart will understate true filing activity. Read the trend as a steady, mature filing pattern rather than either growth or decline until more recent years fully publish.

Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.

Method: Filing trend and technology composition. Derived from a Patsnap search on Hybrid PET/MR and PET/CT Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.